CircSFMBT2 Plays an Oncogenic Role in Lung Adenocarcinoma Depending on the miR-1305/SALL4 Axis
- PMID: 38127171
- DOI: 10.1007/s10528-023-10611-6
CircSFMBT2 Plays an Oncogenic Role in Lung Adenocarcinoma Depending on the miR-1305/SALL4 Axis
Abstract
Circular RNAs (circRNAs) exhibit significant functions in diverse malignant tumors, including lung adenocarcinoma (LUAD). In this study, we aimed to elucidate the role of circRNA scm like with four mbt domains 2 (circSFMBT2) in LUAD. Quantitative real-time polymerase chain reaction (qRT-PCR), western blot assay or immunohistochemistry (IHC) assay was performed for quantification of circSFMBT2, microRNA-1305 (miR-1305), spalt like transcription factor 4 (SALL4), proliferating Cell Nuclear Antigen (PCNA) or Ki-67. 5-ethynyl-2'-deoxyuridine (EdU) assay, transwell assay and flow cytometry analysis were applied to analyze cell proliferation, metastasis and apoptosis, respectively. Mouse xenograft model was established to explore the function of circSFMBT2. Dual-luciferase reporter assay and RNA immunoprecipitation (RIP) assay were used to estimate the relationship between miR-1305 and circSFMBT2 or SALL4. CircSFMBT2 was upregulated in LUAD and related to advanced TNM stage and poor prognosis. CircSFMBT2 knockdown suppressed cell proliferation, metastasis, glycolysis and induced apoptosis in LUAD cells in vitro as well as tumor formation in vivo. CircSFMBT2 directly targeted miR-1305, and miR-1305 inhibition reversed circSFMBT2 knockdown-mediated inhibitory effects on LUAD malignant behaviors. SALL4 was the target gene of miR-1305. MiR-1305 overexpression repressed the malignant phenotypes of LUAD cells, while SALL4 enhancement abated the effects. CircSFMBT2 aggravated the progression of LUAD by the miR-1305/SALL4 axis, which might provide a diagnostic and prognostic marker for LUAD.
Keywords: Lung adenocarcinoma (LUAD); SALL4; circSFMBT2; miR-1305.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Circ-NUP98 Promotes Lung Adenocarcinoma Development Through Regulating CBX1 by miR-188-3p.Biochem Genet. 2024 Oct;62(5):3504-3522. doi: 10.1007/s10528-023-10609-0. Epub 2023 Dec 21. Biochem Genet. 2024. PMID: 38129720
-
Exosomal circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p/tribbles homolog 1 pathway.Anticancer Drugs. 2022 Oct 1;33(9):871-882. doi: 10.1097/CAD.0000000000001365. Epub 2022 Sep 14. Anticancer Drugs. 2022. PMID: 36136987
-
CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.Eur Rev Med Pharmacol Sci. 2021 Feb;25(4):1899-1909. doi: 10.26355/eurrev_202102_25085. Eur Rev Med Pharmacol Sci. 2021. PMID: 33660800
-
The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615-5p/fibronectin 1 pathway.Cell Mol Biol Lett. 2019 Dec 26;24:72. doi: 10.1186/s11658-019-0198-1. eCollection 2019. Cell Mol Biol Lett. 2019. Retraction in: Cell Mol Biol Lett. 2024 Jun 11;29(1):86. doi: 10.1186/s11658-024-00604-7. PMID: 31889960 Free PMC article. Retracted.
-
Depleting hsa_circ_0000567 suppresses acquired gefitinib resistance and proliferation of lung adenocarcinoma cells through regulating the miR-377-3p / ZFX axis: an in vitro and in vivo study.Histol Histopathol. 2022 Jul;37(7):637-654. doi: 10.14670/HH-18-431. Epub 2022 Feb 8. Histol Histopathol. 2022. PMID: 35133000
References
-
- Abdel-Wahab AF, Mahmoud W, Al-Harizy RM (2019) Targeting glucose metabolism to suppress cancer progression: prospective of anti-glycolytic cancer therapy. Pharmacol Res 150:104511. https://doi.org/10.1016/j.phrs.2019.104511 - DOI - PubMed
-
- Alexander M, Kim SY, Cheng H (2020) Update 2020: management of non-small cell lung cancer. Lung 198:897–907. https://doi.org/10.1007/s00408-020-00407-5 - DOI - PubMed - PMC
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492 - DOI - PubMed
-
- Cai Y, Hao Y, Ren H, Dang Z, Xu H, Xue X, Gao Y (2019) miR-1305 inhibits the progression of non-small cell lung cancer by regulating MDM2. Cancer Manag Res 11:9529–9540. https://doi.org/10.2147/cmar.s220568 - DOI - PubMed - PMC
-
- Cai X, Lin L, Zhang Q, Wu W, Su A (2020) Bioinformatics analysis of the circRNA-miRNA-mRNA network for non-small cell lung cancer. J Int Med Res 48:300060520929167. https://doi.org/10.1177/0300060520929167 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous